Navigation Links
New Interactive Web Tool Helps Innovators Match Formulations to Drug Delivery Technologies
Date:11/7/2013

Somerset, NJ (PRWEB) November 07, 2013

Catalent Pharma Solutions, the global leader in development solutions and advanced delivery technologies for drug, biologic and consumer health products, today announced that it is to launch its new ‘FormProRx’ web tool on November 11th, during the forthcoming 2013 American Association of Pharmaceutical Scientists (AAPS) Annual Meeting and Exposition. This innovative web-based scientific resource has been exclusively developed by leading Catalent experts to assist drug development teams seeking to determine the optimal finished dose suited to their product based on product requirements, target indications and molecule properties. FormProRx allows users to assess multiple oral drug delivery technologies in order to establish which may be the most appropriate for their molecule.

Formulators and process development scientists can easily utilize the tool by inputting chemical characteristics and product specifications to generate recommendations based on Catalent’s 75+ years of experience in bioavailability enhancement and applied drug delivery. Users can gain access to a customized report for their Active Pharmaceutical Ingredient (API) Characteristics and product requirements across 24 dimensions under the categories ‘Solubility & Permeability’, ‘Physiochemical Properties’, ‘Potent Handling’ and ‘API Processing.’ On completing the profile, the user then immediately receives a detailed report on which drug delivery technologies could be appropriate for further investigation. Whether for a new drug or a line extension, insights from FormProRx may suggest new approaches that benefit pharmacokinetics, patient adherence or the formulation’s therapeutic profile.

"It is ever more challenging to deliver drugs effectively in a form that is convenient for patients and minimizes side effects. Formulators can drive better outcomes through familiarity with the many drug delivery technologies available." commented Dr. Kurt Nielsen, Chief Technology Officer and Senior Vice President of Innovation and Growth at Catalent. “By introducing a tool that suggests drug delivery technologies based on the specific characteristics of the molecule, and yet is fast and easy-to-use, Catalent aims to help innovators improve their treatments and advance them faster. It is built on the knowledge of many scientists with broad experience developing hundreds of molecules and provides an excellent aid to development teams.”

A trained team of experts will be available to discuss FormProRx and offer live demonstrations at AAPS, Catalent booth (1612). For further information or to schedule a demonstration at the meeting, please contact Richard Kerns at NEPR, richard(at)nepr(dot)eu.

Read the full story at http://www.prweb.com/releases/2013/11/prweb11313849.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Everspark Interactive Attending Kids II Strong Legs Run to Benefit Children’s Healthcare of Atlanta
2. AED.com Releases Interactive Survival Game
3. Dissediting formulates a five step interactive editing service
4. Red Spot Interactive Earns the Position of 554 on 2013 Inc. 500
5. 5000: Annual List Ranks America's Fastest-Growing Private Companies
6. MediStreams to Participate in Interactive Panel Discussion at Upcoming Healthcare Payments Innovation Conference
7. Presence Technology Launches New Interactive Website Focused on Visitors Usability
8. Interactive Pharma Apps: Sell More, Faster, Smarter
9. Progressive Dental Marketing Launches New, Interactive Website
10. PreDiabetes Centers Launches New Interactive Diabetes Risk Survey
11. Everspark Named Interactive Marketing Company for Kids II
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/24/2017)... ... April 24, 2017 , ... Labs often perform the ... for lab operators and management to assess these processes with a critical eye—particularly ... unnecessary actions. , Created with the help of both internal and external ...
(Date:4/24/2017)... , ... April 24, 2017 , ... ... clearly shows that over the last decade, student well-being has seriously declined. "When ... boxes of formal education, join the Islamic State to turn the historic multi-ethnic ...
(Date:4/24/2017)... ... April 24, 2017 , ... “Learning to Use Your SPIRITUAL ... “Learning to Use Your SPIRITUAL COMPASS To Navigate Life Issues” is the creation ... former Chairman of the Board of Directors for CONTACT USA, and former member of ...
(Date:4/24/2017)... (PRWEB) , ... April 24, 2017 , ... ... Gallardo, DDS, PA will be attending the 2017 Oral Reconstruction Foundation’s 2017 Symposium ... , The Oral Reconstruction Foundation will present its annual Global Symposium at the ...
(Date:4/24/2017)... , ... April 24, 2017 , ... ... brands, work wear distributors and International relief organizations across the globe to provide ... also offers lifestyle and work wear collections via insectshield.com . In the ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)...  AbbVie (NYSE: ABBV), a global biopharmaceutical company, ... hepatitis C virus (HCV) infected patients with genotype ... cirrhosis (Child-Pugh A) achieved sustained virologic response at ... investigational, pan-genotypic regimen of glecaprevir/pibrentasvir (G/P). These high ... weeks of G/P treatment without ribavirin. Patients with ...
(Date:4/20/2017)... Sweden , April 20, 2017 ... NEVPF) ("NeuroVive") today announced positive preclinical results ... preclinical compound for non-alcoholic steatohepatitis (NASH), in ... NV556 has previously shown ... NASH model. Today, NeuroVive,s scientists present novel ...
(Date:4/19/2017)... YORK , April 19, 2017 Cardiology devices ... the projected period The Cardiology Devices segment is ... than US$ 15 Mn in 2018 over 2017. By the ... a market valuation close to US$ 700 Mn, expanding at ... Devices segment dominated the Asia Pacific ...
Breaking Medicine Technology: